IPOs and Securities Offerings

Our team members’ experience includes:

IPOs and follow-on offerings

• Served as counsel to a Nasdaq-listed restaurant industry client in connection with its IPO and follow-on equity offerings with an aggregate value of more than $1 billion.
• Served as counsel to a Nasdaq-listed home furnishings retailer in connection with its $168 million IPO.
• Served as counsel to a NYSE-listed investment company in connection with its $240 million IPO.
• Served as counsel to a Nasdaq-listed clinical stage biopharmaceutical company in its IPO and subsequent at-the-market offering aggregating approximately $25 million.
• Served as counsel to an electric vehicle developer in connection with going public and its listing on Nasdaq through a business combination with a SPAC providing approximately $675 million in proceeds.

Debt offerings

• Served as counsel to a NYSE-listed energy industry master limited partnership in its registered $1.6 billion senior notes offering.
• Served as counsel to a NYSE-listed insurance industry client in multiple registered senior notes aggregating more than $3 billion.
• Served as counsel to a Nasdaq-listed restaurant industry client in connection with its $230 million Rule 144A convertible notes offering and its $300 million Rule 144A senior notes offering.
• Served as counsel to a NYSE-listed energy industry client in connection with its refinancing of more than $1 billion of subordinated notes through a combination of tender offers and redemptions, issuances of new common shares, convertible notes and secured notes in privately negotiated exchange transactions, and the registered offering of new notes.
• Served as counsel to a NYSE-listed industrial packaging company in connection with its $500 million Rule 144A senior notes offering to provide acquisition financing.
• Served as counsel to a privately held steel manufacturer in its $600 million Rule 144A secured notes offering, which was the initial debt securities offering for the issuer.
• Served as counsel to a Nasdaq-listed clinical-stage drug discovery and development company in its sale of notes in the principal amount of $55 million.

Other capital market transactions

• Served as counsel to a NYSE-listed insurance industry client in its $500 million registered preferred stock offering.
• Served as counsel to a NYSE-listed energy industry master limited partnership in its $300 million common unit offering.
• Served as counsel to a Nasdaq-listed clinical-stage drug discovery and development company in its fully subscribed $75 million rights offering.
• Served as counsel to a Nasdaq-listed diversified holding entity with healthcare, construction and investment divisions in its public offering of common stock and warrants.
• Served as counsel to an energy-efficient lighting company in connection with its initial listing on Nasdaq and subsequent $50 million underwritten common stock offering.
• Served as counsel to a Nasdaq-listed electric vehicle developer in its equity line of credit for up to $400 million.
• Served as counsel to a Nasdaq-listed IP company in its $10 million litigation financing transaction.
• Served as counsel to an OTC-listed modular homes company in its public rights offering.
• Served as counsel to a Nasdaq-listed IP company in its public rights offering.
• Served as counsel to a Nasdaq-listed biotech company in its $207.2 million overnight public offering of shares of its common stock.
• Served as counsel to a Nasdaq-listed biotech company in several registered direct offerings aggregating more than $100 million.